114 related articles for article (PubMed ID: 9503389)
1. [Pharmacological profile of sendide, a tachykinin NK-1 receptor antagonist].
Kisara K; Tan-No K; Sakurada T
Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):315-24. PubMed ID: 9503389
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
[TBL] [Abstract][Full Text] [Related]
4. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
5. A selective and extremely potent antagonist of the neurokinin-1 receptor.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.
Sakurada S; Orito T; Furuta S; Watanabe H; Mobarakeh JI; Yanai K; Watanabe T; Sato T; Onodera K; Sakurada C; Sakurada T
Pharmacol Biochem Behav; 2003 Jan; 74(2):487-93. PubMed ID: 12479971
[TBL] [Abstract][Full Text] [Related]
7. The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test.
Sakurada T; Katsumata K; Yogo H; Tan-No K; Sakurada S; Ohba M; Kisara K
Pain; 1995 Feb; 60(2):175-180. PubMed ID: 7540280
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord.
Sakurada T; Yamada T; Tan-no K; Manome Y; Sakurada S; Kisara K; Ohba M
J Pharmacol Exp Ther; 1991 Oct; 259(1):205-10. PubMed ID: 1717679
[TBL] [Abstract][Full Text] [Related]
9. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
10. Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test.
Sakurada T; Yogo H; Katsumata K; Tan-No K; Sakurada S; Kisara K; Ohba M
Brain Res; 1994 Jun; 649(1-2):319-22. PubMed ID: 7525010
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
[TBL] [Abstract][Full Text] [Related]
12. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
[TBL] [Abstract][Full Text] [Related]
13. Characterization of intrathecally administered hemokinin-1-induced nociceptive behaviors in mice.
Watanabe C; Mizoguchi H; Yonezawa A; Sakurada S
Peptides; 2010 Aug; 31(8):1613-6. PubMed ID: 20451571
[TBL] [Abstract][Full Text] [Related]
14. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
Zeng XP; Burcher E
J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
[TBL] [Abstract][Full Text] [Related]
15. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
16. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
[TBL] [Abstract][Full Text] [Related]
17. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
19. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
